Therapeutic drug monitoring of mycophenolic acid and clinical outcomes of lupus nephritis: a systema...
Therapeutic drug monitoring of mycophenolic acid and clinical outcomes of lupus nephritis: a systematic review and meta-analysis
About this item
Full title
Author / Creator
Publisher
England: Lupus Foundation of America
Journal title
Language
English
Formats
Publication information
Publisher
England: Lupus Foundation of America
Subjects
More information
Scope and Contents
Contents
IntroductionMycophenolic acid (MPA) is a primary immunosuppressive agent used in the treatment of lupus nephritis (LN). While therapeutic drug monitoring (TDM) of MPA is well established in organ transplantation, its role in LN treatment remains uncertain. Our objective was to review and summarise current knowledge on TDM of MPA in the LN treatment...
Alternative Titles
Full title
Therapeutic drug monitoring of mycophenolic acid and clinical outcomes of lupus nephritis: a systematic review and meta-analysis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_be5b4913b8cf4c5b9ae23cecc380f6a0
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_be5b4913b8cf4c5b9ae23cecc380f6a0
Other Identifiers
ISSN
2053-8790
E-ISSN
2053-8790
DOI
10.1136/lupus-2023-001093
